WO2025219830 - PHARMACEUTICAL COMPOSITIONS OF RIBOCICLIB
National phase entry is expected:
Publication Number
WO/2025/219830
Publication Date
23.10.2025
International Application No.
PCT/IB2025/053835
International Filing Date
11.04.2025
Title **
[English]
PHARMACEUTICAL COMPOSITIONS OF RIBOCICLIB
[French]
COMPOSITIONS PHARMACEUTIQUES DE RIBOCICLIB
Applicants **
NOVARTIS AG
Inventors
CESAR, Jožko
KOPŘIVA, Jan
KUEMMELL, Andreas Karl Georg
LEBEN, Bojana
MIAO, Bukeyan
RAZPOTNIK, Andrej
SCHNEIDER, Hendrik
WAGGER, Jernej
Priority Data
PCT/CN2024/087723
15.04.2024
CN
PCT/CN2024/118001
10.09.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4539 | |
| EPO | Filing, Examination, Granting | 27057 | |
| Japan | Filing, Examination, Granting | 2885 | |
| South Korea | Filing, Examination, Granting | 3504 | |
| USA | Filing, Examination, Granting | 14940 |
Total:
52,925
Contact Us
Abstract[English]
Pharmaceutical compositions of ribociclib ora pharmaceutically acceptable salt thereof are disclosed, wherein the compositions are substantially free of nitrosamines. Pharmaceutical products containing said compositions are also disclosed, as well as methods for preparing and storing said pharmaceutical compositions and pharmaceutical products.[French]
L'invention concerne des compositions pharmaceutiques de ribociclib ou d'un sel pharmaceutiquement acceptable de celui-ci, les compositions étant sensiblement exemptes de nitrosamines. L'invention concerne également des produits pharmaceutiques contenant lesdites compositions, ainsi que des procédés de préparation et de stockage desdites compositions pharmaceutiques et desdits produits pharmaceutiques.